[Gestagen therapy of breast cancer. Effect of high doses on the blood coagulation system].
作者信息
Schenk H, Fereberger W
出版信息
MMW Munch Med Wochenschr. 1983 Oct 7;125(40):875-6.
PMID:6226871
Abstract
摘要
相似文献
1
[Gestagen therapy of breast cancer. Effect of high doses on the blood coagulation system].
MMW Munch Med Wochenschr. 1983 Oct 7;125(40):875-6.
2
[Hormone therapy in metastasized breast cancer. Criteria for establishing indications and implementing high-dose medroxyprogesterone acetate therapy].
Fortschr Med. 1987 Jul 30;105(22):421-4.
3
Oral plus intramuscular medroxyprogesterone acetate (high dose Farlutal) in advanced breast cancer.
Southeast Asian J Trop Med Public Health. 1985 Dec;16(4):634-7.
4
[Plasma lipoprotein fractions in high-dose medroxyprogesterone acetate therapy in metastatic breast cancer].
Gynakol Rundsch. 1991;31(4):189-200.
5
[High-dose gestagen therapy in breast cancer].
Wien Med Wochenschr. 1983 Apr 15;133(7):169-73.
6
Oral route administration of medroxyprogesterone acetate (MAP) at high doses in the treatment of advanced breast cancer: clinical results.
Chemioterapia. 1984 Oct;3(5):320-3.
7
Medroxyprogesterone acetate at very high doses in postmenopausal advanced breast cancer patients.
Chemioterapia. 1987 Dec;6(6):396-8.
8
[High-dosage medroxyprogesterone acetate treatment in advanced prostatic cancer].
Wien Klin Wochenschr. 1987 Oct 9;99(19):682-6.
9
[Oral high-dose medroxyprogesterone acetate (MPA) in the treatment of advanced and recurrent breast cancer: a dose-response evaluation].
Gan To Kagaku Ryoho. 1982 Nov;9(11):1994-2004.
10
[Medroxyprogesterone acetate as glucocorticoid in combination with aminoglutethimide in the treatment of metastatic breast cancer].
Onkologie. 1982 Aug;5 Suppl:34-41.
Zotero 插件